| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.300 | 2.089 | 3.301 | 5.802 | 4.784 | 6.428 | 33.551 | 37.784 | 62.430 | 57.935 |
| Total Income - EUR | 4.300 | 2.089 | 3.301 | 5.802 | 4.784 | 6.734 | 33.551 | 78.340 | 62.430 | 57.935 |
| Total Expenses - EUR | 2.764 | 6.023 | 6.829 | 7.775 | 7.276 | 7.188 | 32.266 | 74.992 | 47.799 | 55.721 |
| Gross Profit/Loss - EUR | 1.536 | -3.935 | -3.528 | -1.973 | -2.492 | -454 | 1.285 | 3.348 | 14.631 | 2.214 |
| Net Profit/Loss - EUR | 1.407 | -3.987 | -3.634 | -2.147 | -2.636 | -646 | 278 | 2.176 | 14.088 | 509 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Euroclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 742 | 592 | 442 | 297 | 157 | 22 | 2.759 | 2.390 | 2.006 | 1.621 |
| Current Assets | 2.935 | 6.366 | 8.327 | 18.520 | 27.280 | 34.652 | 41.758 | 11.907 | 8.581 | 12.986 |
| Inventories | 2.339 | 5.357 | 7.833 | 17.903 | 26.646 | 32.840 | 39.247 | 7.463 | 4.168 | 10.751 |
| Receivables | 365 | 476 | 430 | 344 | 337 | 1.318 | 1.505 | 1.607 | 641 | 939 |
| Cash | 231 | 532 | 64 | 273 | 296 | 493 | 1.007 | 2.837 | 3.772 | 1.297 |
| Shareholders Funds | -11.268 | -15.141 | -18.518 | -20.326 | -22.567 | -22.786 | -22.003 | -19.895 | -5.747 | -5.287 |
| Social Capital | 52 | 51 | 50 | 49 | 48 | 48 | 46 | 47 | 46 | 46 |
| Debts | 14.944 | 22.098 | 27.287 | 39.142 | 50.004 | 57.460 | 66.520 | 34.192 | 16.334 | 19.894 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Euroclinic S.r.l.